Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2.
Melissa KaneStephanie V RebensburgMatthew A TakataTrinity M ZangMasahiro YamashitaMamuka KvaratskheliaPaul D BieniaszPublished in: eLife (2018)
HIV-1 accesses the nuclear DNA of interphase cells via a poorly defined process involving functional interactions between the capsid protein (CA) and nucleoporins (Nups). Here, we show that HIV-1 CA can bind multiple Nups, and that both natural and manipulated variation in Nup levels impacts HIV-1 infection in a manner that is strikingly dependent on cell-type, cell-cycle, and cyclophilin A (CypA). We also show that Nups mediate the function of the antiviral protein MX2, and that MX2 can variably inhibit non-viral NLS function. Remarkably, both enhancing and inhibiting effects of cyclophilin A and MX2 on various HIV-1 CA mutants could be induced or abolished by manipulating levels of the Nup93 subcomplex, the Nup62 subcomplex, NUP88, NUP214, RANBP2, or NUP153. Our findings suggest that several Nup-dependent 'pathways' are variably exploited by HIV-1 to target host DNA in a cell-type, cell-cycle, CypA and CA-sequence dependent manner, and are differentially inhibited by MX2.
Keyphrases
- cell cycle
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv testing
- hiv aids
- hepatitis c virus
- cell proliferation
- men who have sex with men
- protein kinase
- induced apoptosis
- circulating tumor
- signaling pathway
- single molecule
- sars cov
- cell death
- cell cycle arrest
- oxidative stress
- endoplasmic reticulum stress
- small molecule